80 related articles for article (PubMed ID: 9260607)
1. A randomized phase II trial of two different schedules of mitomycin C and vinorelbine in pretreated breast cancer.
Colleoni M; Manente P; Stocker J; Amor H; Lamon S; Nelli P; Vicario G; Sgarbossa G; Graiff C
Oncology; 1997; 54(5):438-9. PubMed ID: 9260607
[No Abstract] [Full Text] [Related]
2. Mitomycin C and vinorelbine in pretreated breast cancer.
Colleoni M; Manente P; Stocker J; Amor H; Lamon S; Nelli P; Vicario G; Sgarbossa G; Graiff C
Tumori; 1997; 83(5):834-6. PubMed ID: 9428918
[TBL] [Abstract][Full Text] [Related]
3. Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study.
De Placido S; Lauria R; Perrone F; Vernaglia Lombardi A; Carlomagno C; Varriale E; Costanzo R; Leo L; De Laurentiis M; Bianco AR
Oncology; 2000; 58(1):8-14. PubMed ID: 10644934
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer.
Kosmas C; Agelaki S; Giannakakis T; Mavroudis D; Kouroussis Ch; Kalbakis K; Papadouris S; Souglakos J; Malamos N; Georgoulias V
Oncology; 2002; 62(2):103-9. PubMed ID: 11914594
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer.
Nabholtz JM; Thuerlimann B; Bezwoda WR; Melnychuk D; Deschênes L; Douma J; Vandenberg TA; Rapoport B; Rosso R; Trillet-Lenoir V; Drbal J; Aapro MS; Alaki M; Murawsky M; Riva A
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):25-30. PubMed ID: 9364538
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients.
Michelotti A; Gennari A; Salvadori B; Giannessi PG; Baldini E; Tibaldi C; Da Prato M; Conte PF
Semin Oncol; 1996 Oct; 23(5 Suppl 11):38-40. PubMed ID: 8893898
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic effects of vinorelbine-based chemotherapy--retrospective study of 65 patients with metastatic or relapsed breast cancer].
Watanabe K; Otake T; Yasuda M; Takenoshita S
Gan To Kagaku Ryoho; 2010 Jan; 37(1):51-6. PubMed ID: 20087032
[TBL] [Abstract][Full Text] [Related]
8. Mitomycin C and vinblastine in anthracycline-resistant metastatic breast cancer: a phase II study.
Kalofonos HP; Onyenadum A; Kosmas C; Koutras A; Petsas T; Efthimiou V; Koukouras D; Tzoracolefterakis E; Andrikopoulos P; Androulakis J
Tumori; 2001; 87(6):394-7. PubMed ID: 11989593
[TBL] [Abstract][Full Text] [Related]
9. Re: Severe neurotoxicity in vinorelbine-paclitaxel combinations.
Budman DR; Weiselberg L; O'Mara V
J Natl Cancer Inst; 1997 Jan; 89(1):87-8. PubMed ID: 8978412
[No Abstract] [Full Text] [Related]
10. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
[TBL] [Abstract][Full Text] [Related]
11. Mitomycin C and vinblastine in combination with amifostine in metastatic breast cancer. A feasibility study of the EORTC--Investigational Drug Branch for Breast Cancer (IDBBC).
Kusenda Z; Kerger J; Awada A; Geurs F; Van Vreckem A; Habboubi N; Piccart MJ
Support Care Cancer; 1997 Sep; 5(5):414-6. PubMed ID: 9322355
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
Chemotherapy; ; . PubMed ID: 20720418
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]